Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0215 per EA under NDC 69097084507. Its NADAC has been published 519 times since Sep 14, 2016.
FDA first approved this application on Jul 23, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084507
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090478FDA Approved
7/23/2010
TE Code
AB
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 519 times since Sep 14, 2016, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0215 per EA |
|---|---|
| All-time high | $0.0470 (Jan 11, 2017) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0219 |
| 52-week low | $0.0209 |
| Median price | $0.0308 |
| Average price | $0.0297 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 519 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cyclobenzaprine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0215 per EA (NDC 69097084507), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 53.3%. It has been tracked across 519 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Sep 14, 2016, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0470 (Jan 11, 2017), with a median of $0.0308 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CYCLOBENZAPRINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 69097084507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.